Proposed Data Collection Submitted for Public Comment and Recommendations, 56955-56956 [2022-20127]
Download as PDF
<![CDATA[
56955
Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Average
burden per
response
(in hours)
Total burden
hours
Form name
Executive .......................
Quasi-Experimental Study Follow-up Survey
Intervention (Form 10).
Quasi-Experimental Study Baseline Interview
Intervention (Form 11).
Quasi Experimental Study Follow-up Interview
Intervention (Form 12).
Quasi-Experimental Study Follow-up Interview
Intervention (Form 15).
15
1
15/60
4
27
1
60/60
27
27
1
60/60
27
6
1
45/60
5
..............................................................................
........................
........................
........................
1,427
Health Worker ................
Health Worker ................
Executive .......................
Total ........................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–20121 Filed 9–15–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–0004; Docket No. CDC–2022–
0108]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice with comment period.
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled National Disease
Surveillance Program—II. Disease
Summaries information collection. This
collection is used to determine the
prevalence of disease and for planning
and evaluating programs for prevention
and control of infectious diseases.
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Type of respondents
CDC must receive written
comments on or before November 15,
2022.
DATES:
You may submit comments,
identified by Docket No. CDC–2022–
0108 by either of the following methods:
ADDRESSES:
VerDate Sep<11>2014
16:43 Sep 15, 2022
Jkt 256001
• Federal eRulemaking Portal:
www.regulations.gov Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
National Disease Surveillance
Program II—Disease Summaries (OMB
Control No. 0920–0004, Exp. 10/31/
2020)—Reinstatement with Change—
National Center for Immunization and
Respiratory Diseases (NCIRD), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC requests a three-year approval for
the Reinstatement with Change of the
National Disease Surveillance Program
II—Disease Summaries information
collection. As with the previous
approval, these data are essential for
measuring trends in diseases, evaluating
the effectiveness of current preventive
strategies, and determining the need to
modify current preventive measures.
Influenza Virus, Caliciviruses,
Respiratory and Enteric Viruses are
associated with diseases in this
surveillance program. Proposed changes
in this Reinstatements with Change
E:\FR\FM\16SEN1.SGM
16SEN1
56956
Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Notices
include the following: nine influenza
forms, Suspect Respiratory Virus Patient
Form, Middle East Respiratory
Syndrome Coronavirus (MERS) Patient
Under Investigation (PUI) Form, Viral
Gastroenteritis Outbreak Submission
Form, National Respiratory and Enteric
Virus Surveillance System (NREVSS)
Laboratory Assessment, and National
Enterovirus Surveillance Report. These
forms will have minor edits with no
burden change from last OMB approval.
In addition to these changes, three
new forms have been added including
discontinued in this package, as they
have been moved to the OMB-approved
package for National Outbreak
Reporting System (NORS) (OMB Control
No. 0920–1304).
an aggregate case count of persons
exposed to Highly Pathogenic Avian
Influenza (HPAI) spreadsheet, Pediatric
Hepatitis of Unknown Etiology Medical
Record Abstraction Form (CRF) and
Pediatric Hepatitis of Unknown Etiology
Medical Record Abstraction short form
version. The data from the new forms
will enable rapid detection and
characterization of outbreaks of known
pathogens, as well as potential newly
emerging viral pathogens. The NORS
Foodborne Disease Transmission, and
Waterborne Diseases Transmission are
The frequency of response for each
form will depend on the disease and
surveillance need. CDC requests OMB
approval for an estimated 24,320 annual
burden hours. There is no additional
cost to respondents other than the time
to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Epidemiologist ...............
WHO COLLABORATING CENTER FOR INFLUENZA Influenza Virus Surveillance.
U.S. WHO Collaborating Laboratories Influenza
Testing Methods Assessment.
U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) Weekly—CDC 55.20.
US Outpatient Influenza-like Illness Surveillance
Network (ILINet) Workfolder 55.20E.
Influenza-Associated Pediatric Mortality—Case
Report Form.
Human Infection with Novel Influenza A Virus
Case Report Form.
Human Infection with Novel Influenza A Virus
Severe Outcomes.
Novel Influenza A Virus Case Screening Form ..
Antiviral Resistant Influenza Infection Case Report Form.
National Respiratory & Enteric Virus Surveillance System (NREVSS) (55.83A, B, D) (electronic).
National Enterovirus Surveillance Report: (CDC
55.9) (electronic).
National Adenovirus Type Reporting System
(NATRS).
Middle East Respiratory Syndrome (MERS) Patient Under Investigation (PUI) Short Form.
Viral Gastroenteritis Outbreak Submission Form
Influenza Virus (Electronic, Year Round),
PHLIP_HL7 messaging Data Elements.
Influenza virus (electronic, year round) (PHIN–
MS).
Suspect Respiratory Virus Patient Form .............
Aggregate case counts of persons exposed to
Highly Pathogenic Avian Influenza (HPAI).
Pediatric Hepatitis of Unknown Etiology Medical
Record Abstraction Short Form.
Pediatric Hepatitis of Unknown Etiology Medical
Record Abstraction Form (CRF).
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
Epidemiologist ...............
khammond on DSKJM1Z7X2PROD with NOTICES
Total ........................
Number of
responses per
respondent
Number of
respondents
Type of respondent
..............................................................................
52
10/60
459
113
1
10/60
19
1800
52
10/60
15,600
1800
1
15/60
150
57
2
30/60
57
57
2
30/60
57
57
1
90/60
86
57
57
1
3
15/60
30/60
14
86
550
52
15/60
7150
20
12
15/60
60
13
4
15/60
13
57
3
25/60
71
20
57
5
52
5/60
5/60
8
247
3
52
5/60
13
10
50
5
9
30/60
10/60
25
75
52
4
15/60
52
52
2
45/60
78
........................
........................
........................
24,320
[FR Doc. 2022–20127 Filed 9–15–22; 8:45 am]
BILLING CODE 4163–18–P
16:43 Sep 15, 2022
Jkt 256001
PO 00000
Frm 00031
Fmt 4703
Total burden
(in hr)
53
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
VerDate Sep<11>2014
Average
burden per
response
(in hr)
Sfmt 4703
E:\FR\FM\16SEN1.SGM
16SEN1
]]>Agencies
[Federal Register Volume 87, Number 179 (Friday, September 16, 2022)]
[Notices]
[Pages 56955-56956]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20127]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-0004; Docket No. CDC-2022-0108]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled National Disease Surveillance Program--II. Disease Summaries
information collection. This collection is used to determine the
prevalence of disease and for planning and evaluating programs for
prevention and control of infectious diseases.
DATES: CDC must receive written comments on or before November 15,
2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0108 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
National Disease Surveillance Program II--Disease Summaries (OMB
Control No. 0920-0004, Exp. 10/31/2020)--Reinstatement with Change--
National Center for Immunization and Respiratory Diseases (NCIRD),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CDC requests a three-year approval for the Reinstatement with
Change of the National Disease Surveillance Program II--Disease
Summaries information collection. As with the previous approval, these
data are essential for measuring trends in diseases, evaluating the
effectiveness of current preventive strategies, and determining the
need to modify current preventive measures.
Influenza Virus, Caliciviruses, Respiratory and Enteric Viruses are
associated with diseases in this surveillance program. Proposed changes
in this Reinstatements with Change
[[Page 56956]]
include the following: nine influenza forms, Suspect Respiratory Virus
Patient Form, Middle East Respiratory Syndrome Coronavirus (MERS)
Patient Under Investigation (PUI) Form, Viral Gastroenteritis Outbreak
Submission Form, National Respiratory and Enteric Virus Surveillance
System (NREVSS) Laboratory Assessment, and National Enterovirus
Surveillance Report. These forms will have minor edits with no burden
change from last OMB approval.
In addition to these changes, three new forms have been added
including an aggregate case count of persons exposed to Highly
Pathogenic Avian Influenza (HPAI) spreadsheet, Pediatric Hepatitis of
Unknown Etiology Medical Record Abstraction Form (CRF) and Pediatric
Hepatitis of Unknown Etiology Medical Record Abstraction short form
version. The data from the new forms will enable rapid detection and
characterization of outbreaks of known pathogens, as well as potential
newly emerging viral pathogens. The NORS Foodborne Disease
Transmission, and Waterborne Diseases Transmission are discontinued in
this package, as they have been moved to the OMB-approved package for
National Outbreak Reporting System (NORS) (OMB Control No. 0920-1304).
The frequency of response for each form will depend on the disease
and surveillance need. CDC requests OMB approval for an estimated
24,320 annual burden hours. There is no additional cost to respondents
other than the time to participate.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hr) (in hr)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Epidemiologist................................. WHO COLLABORATING CENTER FOR INFLUENZA 53 52 10/60 459
Influenza Virus Surveillance.
Epidemiologist................................. U.S. WHO Collaborating Laboratories 113 1 10/60 19
Influenza Testing Methods Assessment.
Epidemiologist................................. U.S. Outpatient Influenza-like Illness 1800 52 10/60 15,600
Surveillance Network (ILINet) Weekly--
CDC 55.20.
Epidemiologist................................. US Outpatient Influenza-like Illness 1800 1 15/60 150
Surveillance Network (ILINet)
Workfolder 55.20E.
Epidemiologist................................. Influenza-Associated Pediatric 57 2 30/60 57
Mortality--Case Report Form.
Epidemiologist................................. Human Infection with Novel Influenza A 57 2 30/60 57
Virus Case Report Form.
Epidemiologist................................. Human Infection with Novel Influenza A 57 1 90/60 86
Virus Severe Outcomes.
Epidemiologist................................. Novel Influenza A Virus Case Screening 57 1 15/60 14
Form.
Epidemiologist................................. Antiviral Resistant Influenza Infection 57 3 30/60 86
Case Report Form.
Epidemiologist................................. National Respiratory & Enteric Virus 550 52 15/60 7150
Surveillance System (NREVSS) (55.83A,
B, D) (electronic).
Epidemiologist................................. National Enterovirus Surveillance 20 12 15/60 60
Report: (CDC 55.9) (electronic).
Epidemiologist................................. National Adenovirus Type Reporting 13 4 15/60 13
System (NATRS).
Epidemiologist................................. Middle East Respiratory Syndrome (MERS) 57 3 25/60 71
Patient Under Investigation (PUI)
Short Form.
Epidemiologist................................. Viral Gastroenteritis Outbreak 20 5 5/60 8
Submission Form.
Epidemiologist................................. Influenza Virus (Electronic, Year 57 52 5/60 247
Round), PHLIP_HL7 messaging Data
Elements.
Epidemiologist................................. Influenza virus (electronic, year 3 52 5/60 13
round) (PHIN-MS).
Epidemiologist................................. Suspect Respiratory Virus Patient Form. 10 5 30/60 25
Epidemiologist................................. Aggregate case counts of persons 50 9 10/60 75
exposed to Highly Pathogenic Avian
Influenza (HPAI).
Epidemiologist................................. Pediatric Hepatitis of Unknown Etiology 52 4 15/60 52
Medical Record Abstraction Short Form.
Epidemiologist................................. Pediatric Hepatitis of Unknown Etiology 52 2 45/60 78
Medical Record Abstraction Form (CRF).
---------------------------------------------------------------
Total...................................... ....................................... .............. .............. .............. 24,320
--------------------------------------------------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-20127 Filed 9-15-22; 8:45 am]
BILLING CODE 4163-18-P
